{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T06:27:32.412087+00:00","published_at":"2026-10-17T04:46:20.15485+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:10040wq1omjfno","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-24","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:daniel-barber-aqst","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:15007dd9948dc30d789bc5a55c866cca9e7317a28ad39d450f0a48d72f7e4e94"],"summary":"Daniel Barber executive of Aquestive Therapeutics, Inc., effective 2026-04-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1c1o2nu13s99fk","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-24","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:lori-j-braender-aqst","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:f182ffbde60d7023a765bcda9259b93b35edc8d15212110466b39bb8a380c440"],"summary":"Lori J. Braender executive of Aquestive Therapeutics, Inc., effective 2026-04-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wyazl81phjfbg","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:abigail-l-jenkins-2","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Abigail L. Jenkins seat on Aquestive Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2h7dvz1q4zobp","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:daniel-barber","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Daniel Barber seat on Aquestive Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:f714813icip7","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:timothy-e-morris-2","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Timothy E. Morris seat on Aquestive Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1gax0fj1qoozzl","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:julie-krop-m-d","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Julie Krop, M.D. seat on Aquestive Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1liypuber94cp","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:marco-taglietti-m-d","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Marco Taglietti, M.D. seat on Aquestive Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14k9bwt1qy5scj","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:gregory-b-brown-m-d","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"Gregory B. Brown, M.D. seat on Aquestive Therapeutics, Inc., effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hhcgqz2ihqb7","event_type":"DIRECTOR_APPOINTED","effective_at":"2004-01-01","detected_at":"2026-10-17T04:46:20.15485+00:00","subject_ids":["alpha:person:john-s-cochran-2","alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5"],"caused_claim_ids":["alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2"],"summary":"John S. Cochran seat on Aquestive Therapeutics, Inc., effective 2004-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:5","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:abigail-l-jenkins-2","object_label":"Abigail L. Jenkins","object_source_name_forms":[],"value":"Abigail L. Jenkins: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:abigail-l-jenkins-2","name":"Abigail L. Jenkins"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:6","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-barber","object_label":"Daniel Barber","object_source_name_forms":[],"value":"Daniel Barber: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-barber","name":"Daniel Barber"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:7","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gregory-b-brown-m-d","object_label":"Gregory B. Brown, M.D.","object_source_name_forms":[],"value":"Gregory B. Brown, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gregory-b-brown-m-d","name":"Gregory B. Brown, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:8","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-s-cochran-2","object_label":"John S. Cochran","object_source_name_forms":[],"value":"John S. Cochran: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-s-cochran-2","name":"John S. Cochran"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2004-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2004-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2004-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:9","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:julie-krop-m-d","object_label":"Julie Krop, M.D.","object_source_name_forms":[],"value":"Julie Krop, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:julie-krop-m-d","name":"Julie Krop, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:10","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:marco-taglietti-m-d","object_label":"Marco Taglietti, M.D.","object_source_name_forms":[],"value":"Marco Taglietti, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:marco-taglietti-m-d","name":"Marco Taglietti, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:11","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-e-morris-2","object_label":"Timothy E. Morris","object_source_name_forms":[],"value":"Timothy E. Morris: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-e-morris-2","name":"Timothy E. Morris"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:16","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:daniel-barber-aqst","object_label":"Daniel Barber","object_source_name_forms":[],"value":"Daniel Barber: Named Executive Officer / Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:daniel-barber-aqst","name":"Daniel Barber"},"title":"Named Executive Officer / Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-24","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:15007dd9948dc30d789bc5a55c866cca9e7317a28ad39d450f0a48d72f7e4e94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AQST DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:34:17.656172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":"2026-04-24","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5:leadership_role:17","subject_id":"alpha:company:a2ff5150-4186-458e-a795-2eb0e1a2cfc5","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lori-j-braender-aqst","object_label":"Lori J. Braender","object_source_name_forms":[],"value":"Lori J. Braender: Named Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lori-j-braender-aqst","name":"Lori J. Braender"},"title":"Named Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-24","valid_to":null,"recorded_at":"2026-10-17T04:46:20.15485+00:00","sources":[{"id":"alpha:projection-evidence:document:f182ffbde60d7023a765bcda9259b93b35edc8d15212110466b39bb8a380c440","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AQST DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:34:18.20455+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":"2026-04-24","effective_until":null,"observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:4fff3aca76696ff04822134f684b2741ae023a67dc84ceb66d6ff8ddba591fa2","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Aquestive Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm","source_date":"2025-04-25","retrieved_at":"2026-04-24T16:22:00.689+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:15007dd9948dc30d789bc5a55c866cca9e7317a28ad39d450f0a48d72f7e4e94","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AQST DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:34:17.656172+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f182ffbde60d7023a765bcda9259b93b35edc8d15212110466b39bb8a380c440","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AQST DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000114036126016757/ny20064249x1_def14a.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:34:18.20455+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.803,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.707,"cross_source_agreement":0.75,"temporal_completeness":0.429},"diagnostics":{"published_claims":28,"factual_claims":28,"claims_with_linked_evidence":28,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:20.15485+00:00","observed_at":"2026-10-17T04:46:20.15485+00:00","reviewed_at":"2026-10-17T04:46:20.15485+00:00","verified_at":"2026-10-17T04:46:20.15485+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":28,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/aquestive-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/aquestive-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}